Empresa Urovant Sciences Ltd.
Acciones
UROV
BMG9381B1081
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 70
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
James Robinson
CEO | Chief Executive Officer | 54 | 01/03/19 |
Ajay Bansal
DFI | Director of Finance/CFO | 62 | 28/10/19 |
Chief Tech/Sci/R&D Officer | 66 | - | |
Ryan Kubota
IRC | Investor Relations Contact | - | - |
Kenton Stewart
SAM | Sales & Marketing | - | 02/06/20 |
Nori Ebersole
HRO | Human Resources Officer | 60 | 01/12/17 |
Walt Johnston
PRN | Corporate Officer/Principal | - | 02/06/20 |
Christine Ocampo
AUD | Comptroller/Controller/Auditor | 51 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
James Hindman
BRD | Director/Board Member | 63 | 20/05/20 |
Sef P. Kurstjens
BRD | Director/Board Member | 60 | 01/07/18 |
James Robinson
CEO | Chief Executive Officer | 54 | 01/03/19 |
Director/Board Member | 59 | 27/12/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 32 743 396 | 5 633 501 ( 17,20 %) | 0 | 17,20 % |
Información de la empresa
Urovant Sciences Ltd.
11-12 Saint James's Square Suite 1
SW1Y 4LB, London
+
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+15,19 % | 121 mil M | |
+19,91 % | 114 mil M | |
+8,24 % | 23,61 mil M | |
-19,80 % | 20,43 mil M | |
-16,19 % | 16,55 mil M | |
-13,45 % | 16,45 mil M | |
-44,35 % | 15,59 mil M | |
+66,67 % | 15,19 mil M | |
+2,13 % | 13,54 mil M |